Finance

Roʻyxatlar
Nega NTRA oshdi 3,08%?
Batafsil oʻrganish
NTRA:NASDAQ
Natera Inc
402,84 US$
+3,08%
(+12,05) 1K
9-okt, 14:14:26 (GMT-4)  ·   USD
Barcha belgilar
BelgiNarxiOʻzgartirishlarDinamika (%)
NTRA tikeri uchun statistika yaratilmoqda...
Ochish
392,90 US$
Yuqori
407,06 US$
Past
391,51 US$
Bozor kapitali
58,07 mlrd
Oʻrtacha hajm
1,64 mln
Hajmi
601,76 ming
52 haftalik eng yuqori
437,41 US$
52 haftalik eng past
167,98 US$
Aksiya boʻyicha daromad
-1,37 US$
Beta
1,50
Muomaladagi aksiyalar
144,14 mln
Xodimlar soni
6 ming
Ochish
392,90 US$
Yuqori
407,06 US$
Past
391,51 US$
Bozor kapitali
58,07 mlrd
Oʻrtacha hajm
1,64 mln
Hajmi
601,76 ming
52 haftalik eng yuqori
437,41 US$
52 haftalik eng past
167,98 US$
Aksiya boʻyicha daromad
-1,37 US$
Beta
1,50
Muomaladagi aksiyalar
144,14 mln
Xodimlar soni
6 ming
Yangiliklar
Internet manbalari va yangilik hamkorlarimizdan
Profil
Natera, Inc. is a clinical genetic testing company based in Austin, Texas that specializes in non-invasive, cell-free DNA testing technology, with a focus on women's health, cancer, and organ health. Natera's proprietary technology combines novel molecular biology techniques with a suite of bioinformatics software that allows detection down to a single molecule in a tube of blood. Natera operates CAP-accredited laboratories certified under the Clinical Laboratory Improvement Amendments in San Carlos, California and Austin, Texas. Wikipedia
Natera Inc haqida
CEOSteven Chapman
Xodimlar soni6,14 ming
Asos solingan1-yan, 2004
Bosh ofislarOstin, Texas, Amerika Qo‘shma Shtatlari
Sektor-
Veb-saytnatera.com
Analitik reytinglar
Oxirgi 3 oyda NTRA aksiyalari boʻyicha reyting bergan 20 tahlilchi xulosasiga koʻra
Sotib olish tavsiya etiladi
Sotib olish
19
Ushlab qolish
1
Sotish
0
12 oylik prognoz
Oxirgi 3 oyda NTRA uchun 12 oylik narx maqsadlarini taklif qilgan 20 Wall Street tahlilchisi xulosasiga koʻra
Eng yuqori
Joriy 402,84 US$
480,00 US$ (+19,15%)
O‘rtacha
383,24 US$ (-4,86%)
Eng past
320,00 US$ (-20,56%)
Analitik
Tavsiya
Amal
Kutilayotgan narx
Prognoz
Sana
Luke Sergott
Barclays
Buy
Maintained
475,00 US$
+17,9%
10/07/2026
Patrick B Donnelly
Citi
Buy
Maintained
480,00 US$
+19,2%
10/06/2026
Albert Hu‏
Citi
Buy
Maintained
480,00 US$
+19,2%
10/06/2026
Subbu Nambi
Guggenheim
Buy
Maintained
475,00 US$
+17,9%
10/01/2026
Eve Burstein
Bernstein
Buy
Maintained
365,00 US$
-9,4%
09/25/2026
Dan Leonard
RBC Capital
Buy
Maintained
460,00 US$
+14,2%
09/24/2026
Evie Koslosky
Goldman Sachs
Hold
Maintained
375,00 US$
-6,9%
09/20/2026
Kallum Titchmarsh
Morgan Stanley
Buy
Maintained
355,00 US$
-11,9%
09/14/2026
Unknown Analyst
UBS
Buy
Maintained
435,00 US$
+8%
09/09/2026
Doug Schenkel
UBS
Buy
Maintained
435,00 US$
+8%
09/09/2026
Jamie Clark
Rothschild & Co Redburn
Buy
Initiated
385,00 US$
-4,4%
09/08/2026
David Westenberg
Piper Sandler
Buy
Maintained
363,50 US$
-9,8%
08/24/2026
Tycho Peterson
Jefferies
Buy
Maintained
330,00 US$
-18,1%
08/17/2026
‏Brendan Digan‏
Citi
Buy
Maintained
365,00 US$
-9,4%
08/14/2026
Unknown Analyst
Stephens
Buy
Maintained
350,00 US$
-13,1%
08/12/2026
Matt Larew
William Blair
Buy
Reiterated
-
-
08/07/2026
Daniel Markowitz CFA
Evercore ISI
Buy
Maintained
360,00 US$
-10,6%
08/07/2026
Catherine Ramsey Schulte
Robert W. Baird
Buy
Maintained
348,00 US$
-13,6%
08/07/2026
Kyle Mikson CFA
Canaccord Genuity
Buy
Maintained
375,00 US$
-6,9%
08/07/2026
Brandon Couillard
Wells Fargo
Hold
Maintained
284,00 US$
-29,5%
08/07/2026
Casey Woodring
J.P. Morgan
Buy
Reiterated
360,00 US$
-10,6%
08/07/2026
Mark Massaro
BTIG
Buy
Reiterated
320,00 US$
-20,6%
08/07/2026
Puneet Souda
Leerink Partners
Buy
Maintained
330,00 US$
-18,1%
08/07/2026
Daniel Brennan
TD Cowen
Buy
Reiterated
340,00 US$
-15,6%
08/07/2026
William Bonello
Craig-Hallum
Buy
Maintained
-
-
07/09/2026
Paige Chamberlain‏
Wolfe Research
Buy
Reiterated
260,00 US$
-35,5%
06/01/2026
Unknown Analyst
Wolfe Research
Buy
Reiterated
260,00 US$
-35,5%
06/01/2026
Andrew Brackmann
William Blair
Buy
Maintained
-
-
05/08/2026
Unknown Analyst
Jefferies
Buy
Reiterated
275,00 US$
-31,7%
02/27/2026
Oxirgi hisobot
6-avg, 2026
Moliya davri
Ch.2 2026
-0,47 US$ / -0,53 US$
+11,99%musbat
Taxminiy daromad (USD)
752,75 mln / 661,29 mln
+13,83%musbat
Q2 2026 uchun tushumlar hisoboti
Tushumlar hisoboti kutilmoqda
Qisqacha
Oxirgi yangiliklar va hisobotlar sarhisobi
Avvalgi hisobotlarBarcha qiymatlar – USD
Loading Previous Earnings...
Daromad
Sof foyda
Barcha qiymatlar – USD
sen, 2025
dek, 2025
mar, 2026
iyn, 2026
Daromad
592,18 mln
665,50 mln
696,64 mln
752,75 mln
Sotilgan mahsulotning tannarxi
207,80 mln
220,07 mln
245,81 mln
267,56 mln
Daromad narxi
207,80 mln
220,07 mln
245,81 mln
267,56 mln
Tadqiqot va ishlanmalarga xarajatlar
173,41 mln
175,19 mln
210,70 mln
228,07 mln
Tadqiqot va ishlanmalarga xarajatlar jami xarajatlar
-
-
-
-
Tijoriy, umumiy va maʼmuriy xarajatlar
308,55 mln
291,30 mln
320,74 mln
328,87 mln
Operatsion xarajatlar
481,96 mln
468,21 mln
537,15 mln
562,65 mln
Jami operatsion xarajatlar
689,76 mln
688,28 mln
782,96 mln
830,21 mln
Operatsion daromad
-97,58 mln
-22,78 mln
-86,32 mln
-77,46 mln
Boshqa nooperatsion daromad
-
-
-
-
Soliq toʻlangunga qadar foyda, shu jumladan gʻayrioddiy moddalar
-87,34 mln
-13,33 mln
-84,81 mln
-67,23 mln
Soliq toʻlangunga qadar foyda, gʻayrioddiy moddalar bundan mustasno
-87,34 mln
-13,33 mln
-77,61 mln
-68,90 mln
Daromad soligʻi boʻyicha xarajat
207,00 ming
-60,58 mln
283,00 ming
-261,00 ming
Amaldagi soliq stavkasi
-0,24%
454,63%
-0,33%
0,39%
Boshqa operatsion xarajatlar
-
-
-
-
Sof foyda
-87,54 mln
47,26 mln
-85,09 mln
-66,97 mln
Sof foyda marjasi
-14,78%
7,10%
-12,21%
-8,90%
Har bir aksiya foydasi
-0,64
0,36
-0,60
-0,47
Foizlar va investitsiyalardan olingan daromadlar
11,28 mln
10,45 mln
9,60 mln
9,45 mln
Foizlarni toʻlash xarajatlari
-1,04 mln
-991,00 ming
-892,00 ming
-890,00 ming
Foizlarni toʻlash boʻyicha sof xarajatlar
10,24 mln
9,46 mln
8,71 mln
8,56 mln
Amortizatsiya ajratmalari
-
-
-
-
EBITDA
-87,28 mln
-13,69 mln
-66,09 mln
-56,27 mln
Aktivlarni sotishdan olingan foyda yoki zarar
-
-
-
-
Insayder tranzaksiyalari
Insayder tranzaksiyalari maʼlumotlari tashqi manbalardan olingan. Batafsil
Insayder
Joylashuvi
Turi
Sana
Aksiyalar
Miqdor
1-sahifa
AI kontentda xatolar boʻlishi mumkin. Batafsil
Google ilovalari